Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Research and development
Compensation and benefits	$ 1,909,518	$ 1,142,198	$ 3,213,358	$ 2,007,401
Consultants and outside costs	194,783	340,289	466,258	604,280
Material manufacturing costs	567,430	755,464	1,079,137	1,375,511
Facilities and other costs	403,648	285,926	802,555	504,951
Research and development	3,075,379	2,523,877	5,561,308	4,492,143
General and administrative
Compensation and benefits	1,285,052	1,170,679	2,151,953	2,117,850
Professional fees	139,865	116,112	286,016	238,173
Investor relations	87,428	57,402	155,535	114,320
General and administrative	301,520	198,466	558,115	403,649
General and administrative	1,813,865	1,542,659	3,151,619	2,873,992
Total operating expenses	4,889,244	4,066,536	8,712,927	7,366,135
Loss from operations	(4,889,244)	(4,066,536)	(8,712,927)	(7,366,135)
Other income (expense)
Interest income	0	193	0	964
Interest expense	0	(1,379)	(1,595)	(2,992)
Derivative gains	1,313	1,729	10,725	14,316
Total other income (expense)	1,313	543	9,130	12,288
Net loss	$ (4,887,931)	$ (4,065,993)	$ (8,703,797)	$ (7,353,847)
Net loss per common share - basic and diluted	$ (0.12)	$ (0.17)	$ (0.23)	$ (0.3)
Weighted average number of common shares outstanding - basic and diluted	40,788,241	24,338,219	38,091,406	24,338,219